Table 1.
Antibody | Clone | Dilution | Source | Stroma around the micropapillary clusters | Tumor cells | ||||
in SMP | outside SMP | ||||||||
Case1 | Case2 | Case1 | Case2 | Case1 | Case2 | ||||
MUC1 | Ma695 | 1:100 | Novocastra | 0 | 0 | 2+ | 2+ | 1+ | 2+ |
EMA | E29 | Pre-diluted | Cell Marque | 0 | 0 | 2+ | 2+ | 2+ | 2+ |
E-cadherin | NCH38D | 1:100 | DakoCytomation | 0 | 0 | 2+ | 2+ | 2+ | 2+ |
CK | AE1/AE3 | Pre-diluted | Nichirei | 0 | 0 | 2+ | 2+ | 2+ | 2+ |
TTF-1 | 8G7G3/1 | 1:100 | DakoCytomation | 0 | 0 | 1+ | 2+ | 2+ | 2+ |
SP-A | PE10 | 1:100 | Dako | 0 | 0 | 1+ | 0 | 2+ | 2+ |
D2-40 | D2-40 | Pre-diluted | Nichirei | 0 | 0 | 0 | 0 | 0 | 0 |
CD34 | Nu-4A1 | Pre-diluted | Nichirei | 0 | 0 | 0 | 0 | 0 | 0 |
FactorVIII | polyclonal | 1:200 | DAKO | 0 | 0 | 0 | 0 | 0 | 0 |
EMA, epithelial membrane antigen; CK, cytokeratin; TTF-1, thyroid transcription factor-1; SP-A, surfactant protein A.
Novocastra, Newcastle Upon Tyne, UK; Cell Marque, Hot springs, AR, USA; DakoCytomation, Carpinteria, CA, USA; Dako, Kyoto, Japan; Nichirei, Tokyo, Japan; DAKO, Glostrup, Denmark.
0, no positive cells; 1+, positive tumor cells less than 10%; 2+, 10% or more.